---
title: L6 Autonomic pharmacology：Adrenergic and Anti-adrenergic Drugs
tags:
  - Molecular Pharmacology
categories:
  - Academic Notebook
  - Molecular Pharmacology
author: 向海
banner_img: >-
  https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/Fluid/post/post2.jpg
top: false
math: true
comments: true
hide: false
excerpt: Adrenergic and Anti-adrenergic Drugs
abbrlink: 29d2c04c
date: 2021-04-16 14:03:06
updated: 2021-04-16 14:03:06
---

**Objectives**

1. To understand the pharmacological effects
2. The mechanisms of drug action
3. Therapeutic applications of alpha and beta adrenergic agonists

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324101410694.png" alt="image-20210324101410694" style="zoom: 33%;" />

# Sympathetic nervous system

Fight or flight response results in:

1. Increased BP
2. Increased blood flow to brain, heart and skeletal muscles
3. Increased muscle glycogenolysis for energy
4. Pupil dilation

## Sympathetic and Parasympathetic Effects on Body Tissues

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324101451325.png" alt="image-20210324101451325" style="zoom: 50%;" />

# Noradrenaline (NA)

Noradrenaline(NA) or norepinephrine(NE)

+ most postganglionic sympathetic fibers (Adrenergic fibers)

### 1. Noradrenaline VS Adrenaline

Noradrenaline is the <u>main neurotransmitter</u> of the sympathetic nerves in the cardiovascular system.

Adrenaline is the <u>main hormone</u> secreted by the **adrenal medulla**. 

The sympathetic noradrenergic system plays major roles in tonic and **reflexive changes** in cardiovascular tone.

Adrenaline is a major determinant of **responses to metabolic or** **global challenges** to homeostasis.

Adrenaline responses to stressors are more closely linked to responses of the hypothalamic‐pituitary‐adrenocortical system than of the sympathetic nervous system.

The sympathetic noradrenergic system is <u>active</u> even when the individual is <u>at rest</u> and maintains tonic levels of cardiovascular performance.

### 2. Synthesis of Adrenaline and Noradrenaline

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102014585.png" alt="image-20210324102014585" style="zoom:100%;" />

+ A **catecholamine**: an organic compound that has a catechol (benzene with two hydroxyl side groups at carbons 1 and 2) and a side-chain amine

### 3. NA synapse: synthesis, storage, release and regulation

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102105466.png" alt="image-20210324102105466" style="zoom:100%;" />

### 4. Norepinephrine degradation

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102126798.png" alt="image-20210324102126798" style="zoom:100%;" />

+ COMT is found in the gut and liver, so catecholamines are not active orally

### 5. Metabolism of NA

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102146363.png" alt="image-20210324102146363" style="zoom:100%;" />

Norepinephrine transporter targeted by amphetamine and cocaine

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102158224.png" alt="image-20210324102158224" style="zoom: 50%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102205797.png" alt="image-20210324102205797" style="zoom: 50%;" />

+ amphetamine is a competitive antagonist,competitively binds the receptor
+ cocaine is noncompetitive antagonist,inhibit the receptor

## Adrenoceptors

Adrenoceptors in the membranes of effector cells determine the physiological and metabolic effects of catecholamines.

**Beta‐adrenoceptors** mediate stimulatory effects of catecholamines on the rate and force of the heartbeat; 

stimulation of vascular **alpha‐adrenoceptors** produces **vasoconstriction** and increases blood pressure, and stimulation of vascular **beta‐adrenoceptors – especially** **beta‐2** adrenoceptors in skeletal muscle – produces **vasodilation**. 

Catecholamines affect cardiovascular functions by actions at adrenoceptors on cardiovascular cells, in the nervous system,and in the kidneys

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102504842.png" alt="image-20210324102504842" style="zoom: 13%;" />

### 1. Signaling pathway of α1 receptor activation

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102534550.png" alt="image-20210324102534550" style="zoom:100%;" />

+ α receptor: α1, α2
+ β receptor: β1,β2,β3

### 2. Signaling pathway of β and α2 receptor

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102605115.png" alt="image-20210324102605115" style="zoom: 70%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102609824.png" alt="image-20210324102609824" style="zoom:100%;" />

### 3. Adrenoceptors: signaling

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102629931.png" alt="image-20210324102629931" style="zoom: 33%;" />

# Sympathetic Responses

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102658990.png" alt="image-20210324102658990" style="zoom: 67%;" />

## Stimulation

### 1. Effects of stimulation of α1 adrenergic receptors

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102729456.png" alt="image-20210324102729456" style="zoom: 70%;" />

### 2. Effects of stimulation of α2 adrenergic receptors

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102752216.png" alt="image-20210324102752216" style="zoom: 60%;" />

### 3. Effects of stimulation of β–adrenergic receptors

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102814275.png" alt="image-20210324102814275" style="zoom: 47%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102841680.png" alt="image-20210324102841680" style="zoom: 30%;" />

### 4. Different role of cAMP in Smooth and Cardiac Muscles

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102917613.png" alt="image-20210324102917613" style="zoom: 50%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324102922859.png" alt="image-20210324102922859" style="zoom: 50%;" />

## Review of functions of sympathetic nervous system receptors

Alpha 1—smooth muscle contraction

Alpha 2-negative feedback causes less norepinephrine to be released so BP is 

reduced

Beta 1—increased heart rate

Beta 2—bronchodilation

Beta 3—actual site for lipolysis

### 1. Adrenoceptor Activating Drugs And Other Sympathomimetics

Sympathomimetics are drugs that partially or completely mimic the action of Epinephrine (E) Or Norepinephrine (NE)

+ Directly – acts on adrenergic receptor
+ Indirectly – stimulates the release Catecholamines (CA) from nerve ending

Classifications: the endogenous biogenic amines (NE, E, DA, ISO)

+ ephedrine and other vasocontractors
+ bronchodilators
+ CNS stimulants

Their effects can be predicted from the knowledge of:

1. The type of adrenergic receptor
2. Property for penetration into CNS
3. Receptor selectivity

## Pharmacological responses of α and β–R agonists

### 1. Cardiovascular system

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324103559851.png" alt="image-20210324103559851" style="zoom: 33%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324103633777.png" alt="image-20210324103633777" style="zoom: 67%;" />

### 2. Eye

Mydriasis (radial pupillary dilator muscle of iris contains → receptors, → stimulation → muscle contraction → pupil dilation)

### 3. Respiratory tract

Bronchial smooth muscle: ß2 receptor → relaxation → bronchodilation

Upper respiratory tract mucosa: → receptors; → stimulants → decongestion

### 4. Gastrointestinal tract

Both α and ß stimulants induce the relaxation of GIT smooth muscle

ß receptor activation (smooth muscle cells) → hyperpolarization → relaxation

α stimulants act indirectly; reduce presynaptically the release of acetylcholine

### 5. Genitourinary tract

Human uterus (α and ß receptors). ß2 receptor stimulation → relaxation

Bladder base and urethral sphincter: α receptor → contraction → continence

Bladder wall: ß2 receptors → relaxation

Ejaculation is dependent upon normal α receptor activity

### 6. Exocrine glands

Salivary gland: increased secretion (mucinous rich saliva,)

Apocrine sweat gland (eg. palms of hands): α stimulants → sweat production ↑

### 7. Metabolic effects

*Fat cells*: ß3 receptor activation → increased lipolysis

*Lipocytes*: α receptor activation → inhibited lipolysis

*Liver*: ß2 & α1 receptor activation → glycogenolysis → blood glucose ↑

*Skeletal muscle*: ß1 receptor activation → glycogenolysis → lactate ↑

### 8. Endocrine function

*Insulin secretion* is stimulated by ß1 and inhibited by α2 stimulation

*Renin secretion* is stimulated by ß1 and inhibited by α2 receptors

**Endogenous** catecholamines: - norepinephrine, epinephrine, dopamine

**Synthetic** catecholamines: - isoproterenol

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324104217606.png" alt="image-20210324104217606" style="zoom:100%;" />

**Substitutions:**

*On the amino group*

+ Increasing the size of the alkyl group → **increased ß and decreased** α **activity**

*On the benzene ring*

+ Maximal α and ß activity is found with CAs (R1 and R2 = OH)
+ Absence of one or two -OH increases **bioavailability**
+ Absence of -OH groups **increases lipid solubility** (potential CNS effects)

*On the* α *carbon*

+ Substitution **blocks the oxydation** by MAO and prolongs the action

*On the* β *carbon*

+ Mostly hydroxyl except Dopamine; facilitates receptor activation and for storage in neural vesicles

# Specific Sympathomimetic Drugs

## Catecholamines Epinephrine (E, Adrenaline)

Acts on both α and ß receptors(low concentration -ß effects, high dose - α effect dominated

### 1. Effects on blood pressure

Low doses of **E**: BP ↓ (ß2 receptor stimulation → **Vasodilatation**, cAMP effect on endothelium)

Large doses of **E**: BP ↑ (α receptor stimulation → **Vasoconstriction**, Ca2+ effect on muscle)

## Norepinephrine (NE, Noradrenaline)

NE is almost equipotent with E on ß1and α receptors but with little effect on ß2 receptors

### 1. Pharmacokinetics of Epinephrine and Norepinephrine

**Poor absorption** following oral administration (rapid conjugation and oxydation)

Slow absorption following subcutaneous administration → local vasoconstriction

**Inhaled solutions** are used in the disease of respiratory tract

They can be given **intravenously**

**Metabolism in the liver** (COMT and MAO); excretion in the urine

### 2. Chemistry and pharmacokinetics

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324105153678.png" alt="image-20210324105153678" style="zoom: 33%;" />

Catecholamines:

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324105212742.png" alt="image-20210324105212742" style="zoom: 50%;" />

Noncatecholamines:

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324105222659.png" alt="image-20210324105222659" style="zoom: 50%;" />

+ Ephedrine: from TCM, 麻黄

## Non-Catecholamines

### 1. Phenylephrine

Pure α receptor agonist, with long duration of action (not inactivated by COMT)

+ Direct acting sympathomimetic, its effects are similar to those of NE but less potent
+ Vasoconstriction, BP ↑, reflex bradycardia occurs after parenteral administration

#### Therapeutic uses

nasal decongestant （endothelium less dilated）

local vasoconstrictor

+ as 10 % ophthalmic solution
+ as an adjunct for use of LA

for relief of paroxysmal atrial tachycardia

#### Adverse effects

Large doses → ventricular arrhythmias (eg. after systemic absorbtion)

Rebound nasal congestion may occur after chronic use

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324110133339.png" alt="image-20210324110133339" style="zoom:100%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324110142591.png" alt="image-20210324110142591" style="zoom: 50%;" />

# Anti-adrenergic Drugs

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324110154196.png" alt="image-20210324110154196" style="zoom:100%;" />

## Classification

1. **α-Adrenoceptor Antagonists** (α adrenergic bolckers)
2. **β- Adrenoceptor Antagonists** (β adrenergic bolckers)
3. **α,β- Adrenoceptor Antagonists** (mixed α,β adrenergic bolckers)

## Pharmacological effects

### 1. blocking α1-R effects

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324110347605.png" alt="image-20210324110347605" style="zoom: 33%;" />

### 2. Blocking α2-R effects

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324110443288.png" alt="image-20210324110443288" style="zoom: 50%;" />

+ block α2 will increase heart rate, because block the negative feedback
+ α2 exixts on the presynaptic surface, end up with lots of NA

### 3. blocking β1-R effects

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324110554015.png" alt="image-20210324110554015" style="zoom: 33%;" />

+ rennin secretion 凝乳酶分泌
+ lowing renal perfusion 降低肾灌注

### 4. blocking β2-R effects

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324110713450.png" alt="image-20210324110713450" style="zoom: 33%;" />

+ bronchial dilation 支气管扩张
+ block beta 3 will cause some severe effects (such as 低血糖)

### 5. α-R block drugs

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324110757213.png" alt="image-20210324110757213" style="zoom: 33%;" />

## Phentolamine

### 1. Pharmacological effects

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324111010025.png" alt="image-20210324111010025" style="zoom: 33%;" />

## β-adrenergic blocking drugs

### 1. Classification

#### Nonselective β-R blockers

full blockers: <u>propranolol</u>, timolol, sotalol, nadolol

with ISA: alprenolol, oxprenolol, pindolol

#### Selective β１-R blockers

full blockers: metoprolol, **esmolol,atenolol**

with ISA: acebutolol

### 2. Pharmacological effects

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324112327970.png" alt="image-20210324112327970" style="zoom: 33%;" />

+ negative inotropic 负性肌力
+ negative chronotropic 负性变时
+ decreased atrioventrical conduction 房室传导阻滞

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324112336817.png" alt="image-20210324112336817" style="zoom: 50%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324112345066.png" alt="image-20210324112345066" style="zoom: 33%;" />

<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210324112356103.png" alt="image-20210324112356103" style="zoom: 50%;" />

+ hypoglycemia for a long time will cause people to die, therefore the hypoglycermia is more dangerous

